Corpus ID: 29355850

The PossibiliTy of encouraging innovaTion and comPeTiTion by erwin a . blacksTone

@inproceedings{Fuhr2015ThePO,
  title={The PossibiliTy of encouraging innovaTion and comPeTiTion by erwin a . blacksTone},
  author={J. Fuhr},
  year={2015}
}

References

SHOWING 1-5 OF 5 REFERENCES
Celltrion’s Opposition to Janssen’s Motion to Dismiss for Lack of Subject Matter Jurisdiction
  • Case No. 1:14cv-11613 (D. Mass., July
  • 2014
Lybecker, When Patents Aren’t Enough: Why Patents Necessitate Data Exclusivity Protection
  • William Mitchell L. Rev
  • 2014
Schondeemeyer, Rx Price Watch Case Study: Efforts to Reduce Impact of Generic Competition for Lipitor
  • AARP Public Policy Institute, Insight on the Issues
  • 2013
The Future of Competition in the Biologics Market
  • Temple J. Sci. Technol. Envir. L
  • 2012
Understanding and Incentivizing Biosimilars
Congress recently passed the Biosimilars Act in an attempt to replicate the success that generic small molecule drugs have enjoyed under the Hatch-Waxman Act. The Biosimilars Act provides a pathwayExpand